Literature DB >> 25698310

Performance of different culture methods and of a commercial molecular assay for the detection of carbapenemase-producing Enterobacteriaceae in nursing homes and rehabilitation centers.

V Saegeman1, J Van den Eynde, L Niclaes, D De Ridder, A Schuermans, Y Glupczynski.   

Abstract

Over the last several years, carbapenemase-producing Enterobacteriaceae (CPE) have been increasingly detected not only among patients in acute care hospitals, but also in long-term care facilities. In this point prevalence survey, residents from three nursing homes and patients in one rehabilitation center were screened for asymptomatic intestinal carriage of CPE by rectal swabs. The first objective was to evaluate the hypothesis of the establishment of a CPE reservoir in a geriatric/chronic care population. Secondly, we evaluated the comparative performances of different culture methods (chromID(®) CARBA, chromID(®) OXA-48, MacConkey with temocillin/meropenem, ertapenem enrichment broth) and a commercial molecular assay (Check-Direct CPE). From the 257 included residents, only one had evidence for CPE carriage. From the rectal swabs of this resident, an OXA-48-producing Klebsiella pneumoniae could be isolated and was confirmed by a molecular assay both on the strain and on the rectal swab. The specificity of the different culture methods and Check-Direct CPE was at least 97 %. Neither enrichment broth nor prolonged incubation up to 48 h increased the yield of CPE. This point prevalence survey shows a low CPE prevalence of 0.39 %. Larger scaled studies are needed in order to confirm the role of chronic care settings as secondary CPE reservoirs and to adjust the infection control and prevention recommendations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25698310     DOI: 10.1007/s10096-015-2318-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in nursing homes: a cross-sectional study.

Authors:  Annette Hoefnagels-Schuermans; Luc Niclaes; Frank Buntinx; Carl Suetens; Beatrice Jans; Jan Verhaegen; Johan Van Eldere
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

2.  Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.

Authors:  Youri Glupczynski; Te-Din Huang; Warda Bouchahrouf; Roberta Rezende de Castro; Caroline Bauraing; Michèle Gérard; Anne-Marie Verbruggen; Ariane Deplano; Olivier Denis; Pierre Bogaerts
Journal:  Int J Antimicrob Agents       Date:  2011-11-23       Impact factor: 5.283

3.  Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs.

Authors:  Roel Nijhuis; Orjan Samuelsen; Paul Savelkoul; Anton van Zwet
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-14       Impact factor: 2.803

4.  Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium.

Authors:  T D Huang; P Bogaerts; C Berhin; B Jans; A Deplano; O Denis; Y Glupczynski
Journal:  Euro Surveill       Date:  2011-06-30

5.  Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.

Authors:  P Reddy; M Malczynski; A Obias; S Reiner; N Jin; J Huang; G A Noskin; T Zembower
Journal:  Clin Infect Dis       Date:  2007-08-20       Impact factor: 9.079

6.  Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.

Authors:  Te-Din Huang; Catherine Berhin; Pierre Bogaerts; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2013-04-03       Impact factor: 5.790

7.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

Review 8.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

9.  Discovery of bla(OXA-199), a chromosome-based bla(OXA-48)-like variant, in Shewanella xiamenensis.

Authors:  Zhiyong Zong
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  9 in total
  5 in total

1.  Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs.

Authors:  Patricia J Simner; Isabella Martin; Belita Opene; Pranita D Tamma; Karen C Carroll; Aaron M Milstone
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

2.  An optimized work-flow to reduce time-to-detection of carbapenemase-producing Enterobacteriaceae (CPE) using direct testing from rectal swabs.

Authors:  C O'Connor; M G Kiernan; C Finnegan; M O'Hara; L Power; N H O'Connell; C P Dunne
Journal:  Bioengineered       Date:  2016-08-17       Impact factor: 3.269

3.  Different Escherichia coli B2-ST131 clades (B and C) producing extended-spectrum β-lactamases (ESBL) colonizing residents of Portuguese nursing homes.

Authors:  C Rodrigues; E Machado; S Fernandes; L Peixe; Â Novais
Journal:  Epidemiol Infect       Date:  2017-10-17       Impact factor: 4.434

Review 4.  Review on colonization of residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other European countries.

Authors:  Richard Aschbacher; Elisabetta Pagani; Massimo Confalonieri; Claudio Farina; Paolo Fazii; Francesco Luzzaro; Pier Giorgio Montanera; Aurora Piazza; Laura Pagani
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-11       Impact factor: 4.887

5.  Carbapenemase screening in an Irish tertiary referral hospital: Best practice, or can we do better?

Authors:  S Fahy; J A O'Connor; D O'Brien; L Fitzpatrick; M O'Connor; J Crowley; M Bernard; R D Sleator; B Lucey
Journal:  Infect Prev Pract       Date:  2020-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.